NASDAQ:LSAQ LifeSci Acquisition II (LSAQ) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free LSAQ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$9.01▼$14.1052-Week Range N/AVolumeN/AAverage Volume53,514 shsMarket Capitalization$57.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisSocial MediaStock AnalysisSocial Media Get LifeSci Acquisition II alerts: Email Address Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. About LifeSci Acquisition IILifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.Read More Ad Stansberry ResearchUrgent dollar warningYour 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today.Find out for free here. LSAQ Stock News HeadlinesDecember 7, 2023 | money.usnews.comNew Providence Acquisition Corp II - Ordinary Shares - Class AMay 23, 2023 | morningstar.comSeaport Global Acquisition II Corp Units (1 Ord Class A & 1/2 War) SGIIU Stock QuoteMay 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).April 20, 2023 | morningstar.comM3 Brigade Acquisition II Corp Ordinary Shares - Class AMarch 11, 2023 | foxnews.comYankees' big deadline acquisition admits he wasn't healthy when traded to New YorkOctober 7, 2021 | finance.yahoo.comWith SPAC deal done, Triangle science company hits public marketsOctober 7, 2021 | finance.yahoo.comScience 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCEOctober 4, 2021 | markets.businessinsider.comOctober SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To WatchMay 2, 2024 | Stansberry Research (Ad)$5,000 Gold?Former Wall Street Banker Reveals Mysterious Gold Leverage As gold continues to soar, this ex-Goldman Sachs VP says DON'T buy bullion or mining stocks. Instead, he's just shared a "gold bank" that uses about $10 of your money to harness the power of two ounces of pure gold (worth about $4,200 right now).July 24, 2021 | investing.comLifesci Acquisition II Corp (LSAQ)See More Headlines Receive LSAQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeSci Acquisition II and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/02/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:LSAQ CUSIPN/A CIK1819113 Weblifesciacquisition.com Phone646-899-1200FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio4.07 Quick Ratio4.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.50 per share Price / BookN/AMiscellaneous Outstanding Shares10,011,000Free FloatN/AMarket Cap$57.56 million OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Andrew Ian McDonald Ph.D. (Age 47)Chairman & CEO Mr. David Dobkin (Age 42)CFO, Head of Strategy & Director Mr. Michael Yehuda Rice (Age 56)COO & Director Key CompetitorsbioAffinity TechnologiesNASDAQ:BIAFInotivNASDAQ:NOTVImmix BiopharmaNASDAQ:IMMXAligos TherapeuticsNASDAQ:ALGSLENZ TherapeuticsNASDAQ:LENZView All Competitors LSAQ Stock Analysis - Frequently Asked Questions When did LifeSci Acquisition II IPO? LifeSci Acquisition II (LSAQ) raised $75 million in an IPO on Friday, November 20th 2020. The company issued 7,500,000 shares at a price of $10.00 per share. LifeSci Capital and Ladenburg Thalmann acted as the underwriters for the IPO. This page (NASDAQ:LSAQ) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsThe biggest energy story ever? Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeSci Acquisition II Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.